Jun 25, 2024 7:30am EDT Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
May 28, 2024 7:03am EDT Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
May 23, 2024 7:03am EDT Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
May 15, 2024 7:03am EDT Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
May 13, 2024 4:16pm EDT Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update
Apr 10, 2024 7:03am EDT Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Mar 28, 2024 4:15pm EDT Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
Mar 25, 2024 7:03am EDT Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
